NCT00004278View on ClinicalTrials.gov

Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

December 31, 1991

Conditions

Cytomegalovirus Infections

Interventions

DRUG

ganciclovir

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

National Center for Research Resources (NCRR)

NIH